Showing results (2151-2160 of 5,049) with videos related to

Sort By:
Pageof 505
Headache|October 31, 2014
A randomized, double-blind, placebo-controlled study of breath powered nasal delivery of sumatriptan powder (AVP-825) in the treatment of acute migraine (The TARGET Study)Roger K Cady, Peter J McAllister, Egilius L H Spierings, et al.
Headache|April 4, 2026
Imaging and physiology across the high-low cerebrospinal fluid pressure spectrum: Navigating diagnostic uncertainty in headache practiceAndrew L Callen, Kyle Jenkins
Headache|April 4, 2026
Randomized controlled trial of intravenous dexamethasone to prevent relapse in the treatment of migraine in a pediatric emergency departmentGeneviève Tourigny-Ruel, Benoit Bailey, Sabrina Jean-Charles, et al.
Headache|April 2, 2026
Arterial hypertension: A safety risk of calcitonin gene-related peptide ligand and receptor blocker classDavid Croteau, Anne Tobenkin, Suprat Saely, et al.
Headache|April 10, 2026
Utility of ANA in hospitalized patients with headache and suspected systemic autoimmune diseaseErez Magiel, Melanie Shanie Roitman, Barak Pflantzer, et al.
Headache|March 28, 2026
Redefining status migrainosus: A narrative reviewJennifer Robblee, Jonathan H Smith, Sarah Ahmad, et al.
Headache|September 20, 2019
Differences of Cluster Headache on the Basis of Sex in the Korean Cluster Headache RegistryPil-Wook Chung, Mi Ji Lee, Jeong-Wook Park, et al.
Headache|March 21, 2023
Sex differences in migraine attack characteristics: A longitudinal E-diary studyIris E Verhagen, Britt W H van der Arend, Daphne S van Casteren, et al.
Headache|June 10, 2026
A phenome-wide association study reveals novel phenotypic determinants of migraine risk in the UK BiobankChanghe Shi, Shuangjie Li, Yuanyuan Liang, et al.
Headache|June 10, 2026
The pharmacology of gepants in migraine: A scoping review on mechanisms, clinical applications, and combination strategiesLuigi Francesco Iannone, Marcello Silvestro, Antonio Munafò, et al.
Pageof 505